home / stock / rmd / rmd articles

RMD Articles, ResMed Inc.

Stock Information
Company Name: ResMed Inc.
Stock Symbol: RMD
Market: NYSE
Website: resmed.com
Menu
RMD RMD Quote RMD Short RMD News RMD Articles RMD Message Board
Get RMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Illumina Rises on Conclusion of GRAIL Divestment | Benzinga

Following three years of nonstop regulatory hassles, Illumina (NASDAQ: ILMN) finally gave up on GRAIL (NASDAQ: GRAL), leading to the successful com...
Abbott's EPD Expansion Continues Despite FX Headwind | Benzinga

Abbott's (NYSE: ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomi...

Why ResMed Shares Are Trading Lower Monday | Benzinga

ResMed, Inc. (NYSE:RMD) stock is trading lower Monday after Eli Lilly and Company (NYSE:LLY) released data from a clinical trial in regards to the ...

ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday | Benzinga

U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Monday. Shares of ResMed Inc. (NYSE:RMD) fell sharply during Monday&#...
Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell' | Benzinga

The U.S. market is on track to open Monday’s session on a firmer note after retreating from its record high in the final two sessions of last...

4 Medical Product Stocks to Buy From a Recovering Industry | Benzinga

The Zacks Medical – Products industry's revenues are expected to continue its growth trajectory on the back of the recovery in demand for...

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today | Benzinga

ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 4.44% on an annualized basis producing an average annual return of 17.24%. ...
Zimmer Biomet Advances in GenAI Technology With RevelAi | Benzinga

Zimmer Biomet (NYSE: ZBH) and RevelAi Health accepted a multi-year co-marketing agreement to commercialize generative artificial intelligence-...

Haemonetics Banks on Growing Plasma Arm, Innovation | Benzinga

Haemonetics (NYSE: HAE) has been gaining from business growth within Plasma, Hospital and Hemostasis Management. Its new launches also aid growth. ...

Abbott Gets FDA Nod for Two Glucose Monitoring Systems | Benzinga

Abbott (NYSE: ABT) announced that Lingo and Libre Rio, two of its glucose monitoring system, have received FDA clearance. Lingo and Libre Rio are b...
Next 10